Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study
Clinical trial NCT04681092 · COMPLETED
Trial details
- NCT number
- NCT04681092
- Sponsor
- University Medical Center Groningen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2022-03-10
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.